🦃 Cozy up with autumn reads! Let our AI Librarian pick your perfect fireside book 🍁
Explore the literary world of this author
NESINA (alogliptin benzoate) drug patents, FDA exclusivity, litigation, drug prices
<h2>NESINA Drug Profile, 2023</h2> <p>This report focuses on NESINA and covers the following critical aspects of this drug:</p> <ul><li>United States ...
ZEPATIER (elbasvir; grazoprevir) drug patents, FDA exclusivity, litigation, drug prices
<h2>ZEPATIER Drug Profile, 2023</h2> <p>This report focuses on ZEPATIER and covers the following critical aspects of this drug:</p> <ul><li>United Sta...
JANUMET (metformin hydrochloride; sitagliptin phosphate) drug patents, FDA exclusivity, litigation, drug prices, sales revenues
<h2>JANUMET Drug Profile, 2023</h2> <p>This report focuses on JANUMET and covers the following critical aspects of this drug:</p> <ul><li>United State...
EDURANT (rilpivirine hydrochloride) drug patents, FDA exclusivity, litigation, drug prices
<h2>EDURANT Drug Profile, 2023</h2> <p>This report focuses on EDURANT and covers the following critical aspects of this drug:</p> <ul><li>United State...
ENTRESTO (sacubitril; valsartan) drug patents, FDA exclusivity, litigation, drug prices
<h2>ENTRESTO Drug Profile, 2023</h2> <p>This report focuses on ENTRESTO and covers the following critical aspects of this drug:</p> <ul><li>United Sta...
ISENTRESS (raltegravir potassium) drug patents, FDA exclusivity, litigation, drug prices
<h2>ISENTRESS Drug Profile, 2023</h2> <p>This report focuses on ISENTRESS and covers the following critical aspects of this drug:</p> <ul><li>United S...
PREZCOBIX (cobicistat; darunavir) drug patents, FDA exclusivity, litigation, drug prices
<h2>PREZCOBIX Drug Profile, 2023</h2> <p>This report focuses on PREZCOBIX and covers the following critical aspects of this drug:</p> <ul><li>United S...
JANUMET XR (metformin hydrochloride; sitagliptin phosphate) drug patents, FDA exclusivity, litigation, drug prices, sales revenues
<h2>JANUMET XR Drug Profile, 2023</h2> <p>This report focuses on JANUMET XR and covers the following critical aspects of this drug:</p> <ul><li>United...
EPCLUSA (sofosbuvir; velpatasvir) drug patents, FDA exclusivity, litigation, drug prices
<h2>EPCLUSA Drug Profile, 2023</h2> <p>This report focuses on EPCLUSA and covers the following critical aspects of this drug:</p> <ul><li>United State...
FYCOMPA (perampanel) drug patents, FDA exclusivity, litigation, drug prices
<h2>FYCOMPA Drug Profile, 2023</h2> <p>This report focuses on FYCOMPA and covers the following critical aspects of this drug:</p> <ul><li>United State...
SAXENDA (liraglutide recombinant) drug patents, FDA exclusivity, litigation, drug prices, sales revenues
<h2>SAXENDA Drug Profile, 2023</h2> <p>This report focuses on SAXENDA and covers the following critical aspects of this drug:</p> <ul><li>United State...
VICTOZA (liraglutide recombinant) drug patents, FDA exclusivity, litigation, drug prices, sales revenues
<h2>VICTOZA Drug Profile, 2023</h2> <p>This report focuses on VICTOZA and covers the following critical aspects of this drug:</p> <ul><li>United State...
XARELTO (rivaroxaban) drug patents, FDA exclusivity, litigation, drug prices, sales revenues
<h2>XARELTO Drug Profile, 2023</h2> <p>This report focuses on XARELTO and covers the following critical aspects of this drug:</p> <ul><li>United State...
NEUPRO (rotigotine) drug patents, FDA exclusivity, litigation, drug prices
<h2>NEUPRO Drug Profile, 2023</h2> <p>This report focuses on NEUPRO and covers the following critical aspects of this drug:</p> <ul><li>United States ...
JENTADUETO (linagliptin; metformin hydrochloride) drug patents, FDA exclusivity, litigation, drug prices
<h2>JENTADUETO Drug Profile, 2023</h2> <p>This report focuses on JENTADUETO and covers the following critical aspects of this drug:</p> <ul><li>United...
VYVANSE (lisdexamfetamine dimesylate) drug patents, FDA exclusivity, litigation, drug prices, sales revenues
<h2>VYVANSE Drug Profile, 2023</h2> <p>This report focuses on VYVANSE and covers the following critical aspects of this drug:</p> <ul><li>United State...
VEMLIDY (tenofovir alafenamide fumarate) drug patents, FDA exclusivity, litigation, drug prices
<p>This report focuses on VEMLIDY and covers the following critical aspects of this drug:</p> <ul><li>United States patents</li> <li>Expired United St...
XIIDRA (lifitegrast) drug patents, FDA exclusivity, litigation, drug prices
<h2>XIIDRA Drug Profile, 2023</h2> <p>This report focuses on XIIDRA and covers the following critical aspects of this drug:</p> <ul><li>United States ...
DESCOVY (emtricitabine; tenofovir alafenamide fumarate) drug patents, FDA exclusivity, litigation, drug prices
<h2>DESCOVY Drug Profile, 2023</h2> <p>This report focuses on DESCOVY and covers the following critical aspects of this drug:</p> <ul><li>United State...
JENTADUETO XR (linagliptin; metformin hydrochloride) drug patents, FDA exclusivity, litigation, drug prices
<h2>JENTADUETO XR Drug Profile, 2023</h2> <p>This report focuses on JENTADUETO XR and covers the following critical aspects of this drug:</p> <ul><li>...
KAZANO (alogliptin benzoate; metformin hydrochloride) drug patents, FDA exclusivity, litigation, drug prices
<h2>KAZANO Drug Profile, 2023</h2> <p>This report focuses on KAZANO and covers the following critical aspects of this drug:</p> <ul><li>United States ...
JANUVIA (sitagliptin phosphate) drug patents, FDA exclusivity, litigation, drug prices, sales revenues
<h2>JANUVIA Drug Profile, 2023</h2> <p>This report focuses on JANUVIA and covers the following critical aspects of this drug:</p> <ul><li>United State...
NUCYNTA ER (tapentadol hydrochloride) drug patents, FDA exclusivity, litigation, drug prices
<h2>NUCYNTA ER Drug Profile, 2023</h2> <p>This report focuses on NUCYNTA ER and covers the following critical aspects of this drug:</p> <ul><li>United...
TRUVADA (emtricitabine; tenofovir disoproxil fumarate) drug patents, FDA exclusivity, litigation, drug prices, sales revenues
<h2>TRUVADA Drug Profile, 2023</h2> <p>This report focuses on TRUVADA and covers the following critical aspects of this drug:</p> <ul><li>United State...
MULTAQ (dronedarone hydrochloride) drug patents, FDA exclusivity, litigation, drug prices
<h2>MULTAQ Drug Profile, 2023</h2> <p>This report focuses on MULTAQ and covers the following critical aspects of this drug:</p> <ul><li>United States ...
OSENI (alogliptin benzoate; pioglitazone hydrochloride) drug patents, FDA exclusivity, litigation, drug prices
<h2>OSENI Drug Profile, 2023</h2> <p>This report focuses on OSENI and covers the following critical aspects of this drug:</p> <ul><li>United States pa...
SYNJARDY XR (empagliflozin; metformin hydrochloride) drug patents, FDA exclusivity, litigation, drug prices
<h2>SYNJARDY XR Drug Profile, 2023</h2> <p>This report focuses on SYNJARDY XR and covers the following critical aspects of this drug:</p> <ul><li>Unit...
TIVICAY (dolutegravir sodium) drug patents, FDA exclusivity, litigation, drug prices
<h2>TIVICAY Drug Profile, 2023</h2> <p>This report focuses on TIVICAY and covers the following critical aspects of this drug:</p> <ul><li>United State...
NAMZARIC (donepezil hydrochloride; memantine hydrochloride) drug patents, FDA exclusivity, litigation, drug prices
<h2>NAMZARIC Drug Profile, 2023</h2> <p>This report focuses on NAMZARIC and covers the following critical aspects of this drug:</p> <ul><li>United Sta...
RELISTOR (methylnaltrexone bromide) drug patents, FDA exclusivity, litigation, drug prices
<h2>RELISTOR Drug Profile, 2023</h2> <p>This report focuses on RELISTOR and covers the following critical aspects of this drug:</p> <ul><li>United Sta...
MOVIPREP (ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate) drug patents, FDA exclusivity, litigation, sales revenues
<h2>MOVIPREP Drug Profile, 2023</h2> <p>This report focuses on MOVIPREP and covers the following critical aspects of this drug:</p> <ul><li>United Sta...
VIMOVO (esomeprazole magnesium; naproxen) drug patents, FDA exclusivity, litigation, sales revenues
<h2>VIMOVO Drug Profile, 2023</h2> <p>This report focuses on VIMOVO and covers the following critical aspects of this drug:</p> <ul><li>United States ...
ONGLYZA (saxagliptin hydrochloride) drug patents, FDA exclusivity, litigation, drug prices, sales revenues
<h2>ONGLYZA Drug Profile, 2023</h2> <p>This report focuses on ONGLYZA and covers the following critical aspects of this drug:</p> <ul><li>United State...
ANORO ELLIPTA (umeclidinium bromide; vilanterol trifenatate) drug patents, FDA exclusivity, litigation, drug prices
<h2>ANORO ELLIPTA Drug Profile, 2023</h2> <p>This report focuses on ANORO ELLIPTA and covers the following critical aspects of this drug:</p> <ul><li>...
FORTEO (teriparatide) drug patents, FDA exclusivity, litigation, drug prices
<h2>FORTEO Drug Profile, 2023</h2> <p>This report focuses on FORTEO and covers the following critical aspects of this drug:</p> <ul><li>United States ...
INVOKANA (canagliflozin) drug patents, FDA exclusivity, litigation, drug prices, sales revenues
<h2>INVOKANA Drug Profile, 2023</h2> <p>This report focuses on INVOKANA and covers the following critical aspects of this drug:</p> <ul><li>United Sta...
SUBOXONE (buprenorphine hydrochloride; naloxone hydrochloride) drug patents, FDA exclusivity, litigation, drug prices, sales revenues
<h2>SUBOXONE Drug Profile, 2023</h2> <p>This report focuses on SUBOXONE and covers the following critical aspects of this drug:</p> <ul><li>United Sta...
XIFAXAN (rifaximin) drug patents, FDA exclusivity, litigation, drug prices, sales revenues
<h2>XIFAXAN Drug Profile, 2023</h2> <p>This report focuses on XIFAXAN and covers the following critical aspects of this drug:</p> <ul><li>United State...
VIBERZI (eluxadoline) drug patents, FDA exclusivity, litigation, drug prices
<h2>VIBERZI Drug Profile, 2023</h2> <p>This report focuses on VIBERZI and covers the following critical aspects of this drug:</p> <ul><li>United State...
BYETTA (exenatide synthetic) drug patents, FDA exclusivity, litigation, drug prices, sales revenues
<h2>BYETTA Drug Profile, 2023</h2> <p>This report focuses on BYETTA and covers the following critical aspects of this drug:</p> <ul><li>United States ...